Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Purchase of 10,000 EVMN shares, $133.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | Evommune, Inc. (EVMN) | Purchase | 10,000 | $133.0K |
| Jun 23, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 26,700 | n/a |
| Jun 18, 2026 | Liquidia Corp (LQDA) | Grant/Award | 5,882 | n/a |
| Jun 4, 2026 | Evommune, Inc. (EVMN) | Grant/Award | 15,673 | n/a |
| Jun 3, 2026 | Liquidia Corp (LQDA) | Sale | 15,000 | $903.3K |
| Nov 7, 2025 | Evommune, Inc. (EVMN) | Grant/Award | 37,960 | n/a |
| Jun 20, 2025 | Liquidia Corp (LQDA) | Grant/Award | 18,396 | n/a |
| Feb 24, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 164,800 | n/a |
| Jun 25, 2024 | Liquidia Corp (LQDA) | Grant/Award | 20,359 | n/a |
| Jun 21, 2023 | Liquidia Corp (LQDA) | Grant/Award | 20,000 | n/a |